Biotechnology - Anti-virals, Prezista

Filter

Current filters:

Anti-viralsPrezista

Popular Filters

Gilead in another licensing deal with J&J unit for combo HIV/AIDS treatment

16-11-2011

US biotech firm Gilead Sciences (Nasdaq: GILD) has entered into a license agreement with Tibotec Pharmaceuticals,…

Anti-viralsBiotechnologycobicistatEmtrivaGilead SciencesJohnson & JohnsonLicensingPharmaceuticalPrezistaResearchTibotec

Back to top